Characterization of scratching behavior induced by intradermal administration of morphine and fentanyl in mice

European Journal of Pharmacology

Volumn 627, Issue 1-3, 2010, Pages 162-166

  Yamamoto, Atsuki ^a   Kuyama, Shoji ^a   Kamei, Chiaki ^a   Sugimoto, Yukio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Fentanyl; Itch; Morphine; Naloxone methiodide; Peripheral opioid receptor; Scratching behavior

Indexed keywords

17 METHYLNALOXONE; ARACHIDONIC ACID; CETIRIZINE; CHLORPHENIRAMINE; DEXAMETHASONE; DIPHENHYDRAMINE; EPINASTINE; FENTANYL; GLUCOCORTICOID; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; MORPHINE; NALOXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; PREDNISOLONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; MALE; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PRURITUS; SCRATCHING;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; FENTANYL; HISTAMINE H1 ANTAGONISTS; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRADERMAL; MALE; MICE; MICE, INBRED ICR; MORPHINE; NALOXONE; PRURITUS; RECEPTORS, OPIOID;

EID: 73449090756     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.10.066     Document Type: Article

References (28)

1. Bigliardi P.L., Stammer H., Jost G., Rufli T., Büchner S., and Bigliardi-Qi M. Treatment of pruritus with topically applied opiate receptor antagonist. J. Am. Acad. Dermatol. 56 (2007) 979-988
2. Bigliardi P.L., Tobin D.J., Gaveriaux-Ruff C., and Bigliardi-Qi M. Opioids and the skin-where do we stand?. Exp. Dermatol. 18 (2009) 424-430
3. Bigliardi-Qi M., Sumanovski L.T., Büchner S., Rufli T., and Bigliardi P.L. Mu-opiate receptor and Beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology 209 (2004) 183-189
4. Bigliardi-Qi M., Lipp B., Sumanovski L.T., Buechner S.A., and Bigliardi P.L. Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology 210 (2005) 91-99
5. Blunk J.A., Schmelz M., Zeck S., Skov P., Likar R., and Koppert W. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth. Analg. 98 (2004) 364-370
6. Brune A., Metze D., Luger T.A., and Ständer S. Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients. Hautarzt 55 (2004) 1130-1136
7. Casale T.B., Bowman S., and Kaliner M. Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation. J. Allergy Clin. Immunol. 73 (1984) 775-781
8. Cherny N., Ripamonti C., Pereira J., Davis C., Fallon M., McQuay H., Mercadante S., Pasternak G., and Ventafridda V. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J. Clin. Oncol. 19 (2001) 2542-2554
9. Dawn A.D., and Yosiptovitch G. Butorphanol for treatment of intractable pruritus. J. Am. Acad. Dermatol. 54 (2006) 527-531
10. Doenicke A., Moss J., Lorenz W., and Hoernecke R. Intravenous morphine and nalbuphine increase histamine and catecholamine release without accompanying hemodynamic changes. Clin. Pharmacol. Ther. 58 (1995) 81-89
11. Jones E.A., Neuberger J., and Bergasa N.V. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. QJM 95 (2002) 547-552
12. Ko M.C., Song M.S., Edwards T., Lee H., and Naughton N.N. The role of central mu opioid receptors in opioid-induced itch in primates. J. Pharmacol. Exp. Ther. 310 (2004) 169-176
13. Kostopanagiotou G., Pandazi A., Matiatou S., Kontogiannopoulou S., Matsota P., Niokou D., Kitsou M., Crepi E., Christodoulaki K., and Grigoropoulou I. The impact of intraoperative propofol administration in the prevention of postoperative pruritus induced by epidural morphine. Eur. J. Anaesthesiol. 23 (2006) 418-421
14. Kuraishi Y., Yamaguchi T., and Miyamoto T. Itch-scratch responses induced by opioids through central mu opioid receptors in mice. J. Biomed. Sci. 7 (2000) 248-252
15. Kyriakides K., Hussain S.K., and Hobbs G.J. Management of opioid-induced pruritus: a role for 5-HT3 antagonists?. Br. J. Anaesth. 82 (1999) 439-441
16. Levy J.H., Brister N.W., Shearin A., Ziegler J., Hug Jr. C.C., Adelson D.M., and Walker B.F. Wheal and flare responses to opioids in humans. Anesthesiology 70 (1989) 756-760
17. Maekawa T., Nojima H., and Kuraishi Y. Itch-associated responses of afferent nerve innervating the murine skin: different effects of histamine and serotonin in ICR and ddY mice. Jpn. J. Pharmacol. 84 (2000) 462-466
18. Mansour-Ghanaei F., Taheri A., Froutan H., Ghofrani H., Nasiri-Toosi M., Bagherzadeh A.H., Farahvash M.J., Mirmomen S., Ebrahimi-Dariani N., Farhangi E., and Pourrasouli Z. Effect of oral naltrexone on pruritus in cholestatic patients. World J. Gastroenterol. 21 (2006) 1125-1128
19. McNicol E., Horowicz-Mehler N., Fisk R.A., Bennett K., Gialeli-Goudas M., Chew P.W., Lau J., and Carr D. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J. Pain 4 (2003) 231-256
20. Morita T., and Tei Y. Skin reaction to both morphine and fentanyl attenuated by steroids and antihistaminics. J. Pain Symptom Manag. 32 (2006) 100-101
21. Murphy D.B., Sutton J.A., Prescott L.F., and Murphy M.B. Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology 87 (1997) 765-770
22. Sartain J.B., Barry J.J., Richardson C.A., and Branagan H.C. Effect of combining naloxone and morphine for intravenous patient-controlled analgesia. Anesthesiology 99 (2003) 148-151
23. Sugimoto Y., Umakoshi K., Nojiri N., and Kamei C. Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice. Eur. J. Pharmacol. 12 (1998) 1-5
24. Thomas D.A., Williams G.M., Iwata K., Kenshalo Jr. D.R., and Dubner R. Effects of central administration of opioids on facial scratching in monkeys. Brain Res. 10 (1992) 315-317
25. Ueda Y., Inoue T., Rahman M.A., Yatsuzuka R., Jiang S., and Kamei C. A new chronic itch model accompanied by skin lesions in hairless mice. Int. Immunopharmacol. 6 (2006) 1609-1615
26. Wells J., Paech M.J., and Evans S.F. Intrathecal fentanyl-induced pruritus during labour: the effect of prophylactic ondansetron. Int. J. Obstet. Anesth. 13 (2004) 35-39
27. Yamaguchi T., Maekawa T., Nishikawa Y., Nojima H., Kaneko M., Kawakita T., Miyamoto T., and Kuraishi Y. Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis. J. Dermatol. Sci. 25 (2001) 20-28
28. Yuan C.S., Foss J.F., O'Connor M., Osinski J., Roizen M.F., and Moss J. Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine. Drug Alcohol Depend. 1 (1998) 161-165